EP 3 049 439 B1 relates to bispecific polypeptides.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The MR corresponds to the patent as granted.
The opponent did not attend the OP before the board,
T 1019/22 – An obiter dictum cannot replace a decision
by Daniel X. Thomas